These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8334682

  • 21. Effect of liposome-muramyl tripeptide combined with recombinant canine granulocyte colony-stimulating factor on canine monocyte activity.
    Kurzman ID, Cheng H, MacEwen EG.
    Cancer Biother; 1994; 9(2):113-21. PubMed ID: 7529085
    [Abstract] [Full Text] [Related]

  • 22. A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers.
    Venkatakrishnan K, Kramer WG, Synold TW, Goodman DB, Sides E, Oliva C.
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1347-55. PubMed ID: 22460239
    [Abstract] [Full Text] [Related]

  • 23. Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma.
    Liebes L, Walsh CM, Chachoua A, Oratz R, Richards D, Hochster H, Peace D, Marino D, Alba S, Le Sher D.
    J Natl Cancer Inst; 1992 May 06; 84(9):694-9. PubMed ID: 1569602
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.
    Shi F, Kurzman ID, MacEwen EG.
    Cancer Biother; 1995 May 06; 10(4):317-25. PubMed ID: 8590897
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.
    Kleinerman ES, Gano JB, Johnston DA, Benjamin RS, Jaffe N.
    Am J Clin Oncol; 1995 Apr 06; 18(2):93-9. PubMed ID: 7900714
    [Abstract] [Full Text] [Related]

  • 26. Induction and maintenance of monocyte cytotoxicity during treatment with liposomes containing muramyl tripeptide despite tachyphylaxis to the cytokine response.
    Galligioni E, Favaro D, Santarosa M, Quaia M, Spada A, Freschi A, Alberti D.
    Clin Cancer Res; 1995 May 06; 1(5):493-9. PubMed ID: 9816008
    [Abstract] [Full Text] [Related]

  • 27. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE): a randomized clinical trial in dogs with mammary carcinoma.
    Teske E, Rutteman GR, vd Ingh TS, van Noort R, Misdorp W.
    Anticancer Res; 1998 May 06; 18(2A):1015-9. PubMed ID: 9615757
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid).
    Fujimaki W, Itoh K, An T, Gano JB, Ross MI, Mansfield PF, Balch CM, Augustus LB, Karkevitch DD, Johnston D.
    Cancer Biother; 1993 May 06; 8(4):307-18. PubMed ID: 7804372
    [Abstract] [Full Text] [Related]

  • 32. Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma.
    Nardin A, Lefebvre ML, Labroquère K, Faure O, Abastado JP.
    Curr Cancer Drug Targets; 2006 Mar 06; 6(2):123-33. PubMed ID: 16529542
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Soluble intercellular adhesion molecule-1 and serum cytokines in melanoma patients treated with liposomes containing muramyl tripeptide.
    Favaro D, Santarosa M, Quaia M, Spada A, Freschi A, Talamini R, Galligioni E.
    Tumori; 1995 Mar 06; 81(3):185-90. PubMed ID: 7571025
    [Abstract] [Full Text] [Related]

  • 36. [L-MTP-PE--a potential antineoplastic agent].
    Dzierzbicka K, Gozdowska M, Kołodziejczyk AM.
    Postepy Hig Med Dosw; 1997 Mar 06; 51(2):227-36. PubMed ID: 9235567
    [Abstract] [Full Text] [Related]

  • 37. Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE.
    Gay B, Cardot JM, Schnell C, van Hoogevest P, Gygax D.
    J Pharm Sci; 1993 Oct 06; 82(10):997-1001. PubMed ID: 8254500
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide.
    Landmann R, Obrist R, Denz H, Ludwig C, Frost H, Wesp M, Rordorf C, Towbin H, Gygax D, Tarcsay L.
    Biotherapy; 1993 Oct 06; 7(1):1-12. PubMed ID: 8068481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.